hematoxylin has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iliev, A; Kotov, G; Landzhov, B; Stamenov, N; Stanchev, S | 1 |
| Celes, MR; Prado, CM; Rossi, MA; Saggioro, FP | 1 |
2 other study(ies) available for hematoxylin and Heart Diseases
| Article | Year |
|---|---|
Changes in the number of mast cells, expression of fibroblast growth factor-2 and extent of interstitial fibrosis in established and advanced hypertensive heart disease.
Topics: Age Factors; Animals; Azo Compounds; Coloring Agents; Eosine Yellowish-(YS); Fibroblast Growth Factor 2; Fibrosis; Fluorescent Dyes; Heart Diseases; Heart Ventricles; Hematoxylin; Hypertension; Immunohistochemistry; Male; Mast Cells; Methyl Green; Myocardium; Rats; Rats, Inbred SHR; Tolonium Chloride | 2020 |
Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction.
Topics: Adult; Aged; Eosine Yellowish-(YS); Female; Heart Diseases; Hematoxylin; Humans; Male; Middle Aged; Myocardium; Sepsis; Shock, Septic | 2007 |